Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire Dijon
Age
Any age
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
I- PATIENTS
men or women
who have been informed about the study
and who have provided verbal consent to take part in the study
able to understand written and spoken French
with non-resectable metastatic cancer of: the colon, or the rectosigmoid junction or the stomach or bile ducts or rectum or gastrointestinal neuroendocrine tumor or lung (not small-cell cancer) or pancreas
with a caregiver designated as the principal caregiver (family, friend, neighbour)
who has consented to the principal caregiver taking part in a qualitative interview
able to take part in an interview lasting roughly one hour
II- CAREGIVERS
men or women
who have been informed about the study
who have provided verbal consent to take part in the study
able to understand written and spoken French
able to follow an interview lasting roughly one hour
III-DOCTORS
men or women
who have been informed about the study
who have provided verbal consent to take part in the study
specialised in specific organ or oncologist prescriber
You may not be if
I- PATIENTS
under guardianship or ward of court
with a severe handicap (neurological disease: Parkinson, Alzheimer, other dementia, multiple sclerosis, severe mental retardation etc.)
II- CAREGIVERS
under guardianship or ward of court,
with a severe handicap (neurological disease: Parkinson, Alzheimer, other dementia, multiple sclerosis…),
with severe mental retardation impairing ability to understand.
Clareo Health | Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours
